This compound is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of drugs targeting the central nervous system. It serves as a key intermediate in the production of compounds that modulate neurotransmitter activity, making it valuable in the creation of treatments for neurological disorders such as depression, anxiety, and schizophrenia. Additionally, its structure is often employed in the design of selective serotonin reuptake inhibitors (SSRIs) and other psychotropic agents. The presence of the BOC-protected amine group allows for controlled deprotection during synthesis, enabling precise modification of the molecule for desired pharmacological activity. Its role in medicinal chemistry underscores its importance in advancing therapeutic options for mental health conditions.